Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Govaere, O., Cockell, S., TINIAKOS, D.G., Queen, R.A., Younes, R., Vacca, M., Alexander, L.E., Ravaioli, F., Palmer, J.M., Petta, S., Boursier, J., Rosso, C., Johnson, K., Wonders, K., Day, C.P., Ekstedt, M., Orešič, M., Darlay, R., Cordell, H.J., &amp; Marra, F. (2020). Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. <em>Science Translational Medicine</em>. https://doi.org/10.1126/scitranslmed.aba4448

Govaere O, Cockell S, TINIAKOS DG, Queen RA, Younes R, Vacca M, et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Science Translational Medicine. 2020. doi:10.1126/scitranslmed.aba4448.

@unpublished{olivier2020Transc, title = {Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis}, author = {Olivier Govaere and Simon Cockell and DINA G. TINIAKOS and Rachel A. Queen and Ramy Younes and Michèle Vacca and Leigh E. Alexander and Federico Ravaioli and Jeremy M. Palmer and Salvatore Petta and Jérôme Boursier and Chiara Rosso and Katherine Johnson and Kristy Wonders and Christopher Paul Day and Mattias Ekstedt and Matej Orešič and Rebecca Darlay and Heather Jane Cordell and Fabio Marra and Antonio Vidal‐Puig and Pierre Bédossa and Jörn Markus Schattenberg and Karine Clément and Michael Allison}, journal = {Science Translational Medicine}, year = {2020}, doi = {10.1126/scitranslmed.aba4448}, }